Companies: 10,795·Total market cap: $144.5T
The Beauty Health Company

The Beauty Health Company

SKINNASDAQConsumer Defensive● Active
$0.63
+$0.03(+4.18%)
Market Cap$82036802
P/E Ratio
52W High$2.69
52W Low$0.551
Overview

The Beauty Health Company (SKIN) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

skin · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 14 Wall Street analysts in the past 3 months

SellBuy

Hold

14 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
4
Hold
7
Sell
3
Strong Sell
0
Total: 14 · Buy rate: 28.6%

12-Month Price Target

High

$2.00

Consensus

$1.53

+139.6% upside

Low

$1.00

Median: $1.6 · Last Close: $0.64

The The Beauty Health Company (SKIN) analyst consensus is Hold, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month SKIN price target is $1.53, representing +139.6% upside from the current price of $0.64.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $2 (139.6%)

Consensus Target

$1.53

139.6% upside

High Target

$2

213.2%

Low Target

$1

56.6%

Current Price

$0.64

as of today

Based on analyst price targets, the SKIN stock price prediction for the next 12 months ranges from $1 to $2. The consensus SKIN price forecast of $1.53 implies 139.6% upside from the current price of $0.64.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$0.615.00%

1-day model range: $0.59–$0.62. Peak: $0.62 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$0-50.0%
2028$0-62.5%
2029$0-67.2%
2030$0-69.2%
2031-70.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%7%86%
1Buy
1Neutral
12Sell
RSI (14)52.9Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · SKIN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$0.63BUY
MA 10$0.71SELL
MA 20$0.68SELL
MA 50$0.80SELL
MA 100$1.01SELL
MA 200$1.33SELL
Current $SKIN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.64SELL
EMA 10$0.67SELL
EMA 20$0.70SELL
EMA 50$0.81SELL
EMA 100$0.97SELL
EMA 200$1.20SELL
Current $SKIN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Roth Capital2026-05-20
Maintains
BuyBuy
Canaccord Genuity2026-05-01
Maintains
HoldHold
TD Cowen2026-03-16
Maintains
HoldHold
Canaccord Genuity2026-03-13
Maintains
HoldHold
TD Cowen2026-01-21
Maintains
HoldHold
TD Cowen2025-09-22
Maintains
HoldHold
Stifel2025-08-01
Maintains
HoldHold
Canaccord Genuity2025-05-05
Maintains
HoldHold
Canaccord Genuity2025-03-13
Maintains
HoldHold
Canaccord Genuity2024-11-13
Maintains
HoldHold

Wall Street analysts have recently issued updated ratings on The Beauty Health Company (SKIN) stock. Of the recent 74 rating actions, 1 were upgrades and 10 were downgrades. 14 analysts currently cover SKIN.

Analyst Recommendation Trends

Buy ratings01↑ +1
Hold ratings11
Sell ratings00

SKIN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$328M

↑ 13.3% YoY

Revenue Next Year

$297M

↓ 9.5% YoY

EPS This Year

$-0.28

EPS Next Year

$-0.07

↓ 74.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SKIN EPS of $-0.28 for the current fiscal year, based on estimates from 3 analysts. The SKIN revenue forecast is $328M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The SKIN stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SKIN price target is $1.53 (+139.6% upside), with an analyst consensus of Hold.

The SKIN short-term stock prediction for tomorrow is $0.61 (-5.00%). The SKIN stock price prediction for 2027 estimates an average of $0. The SKIN stock prediction for 2030 projects a range of $0–$0.

The Beauty Health Company trades on NASDAQ under the ticker SKIN. The SKIN stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 29% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

SKIN forecast · 8 questions

According to 14 Wall Street analysts, the average 12-month SKIN price target is $1.53, with a high forecast of $2.00 and a low of $1.00. The median price target is shown in the chart above when available. This implies +139.6% potential upside from the current price of $0.64.

SKIN price targetWhat is SKIN price targetSKIN analyst price targetSKIN 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.